Overview

Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter

Status:
Terminated

Trial end date:
2012-07-16

Target enrollment:

Participant gender:

Summary

CV185-079 is a multiple dose Apixaban Pharmacokinetics/Pharmacodynamics (PK/PD) study in pediatric subjects. The objective of this study is primarily to study the PK/PD of Apixaban in pediatric subjects with a central venous catheter.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb

Collaborator:

Pfizer

Treatments:

Apixaban